CME COURSE- PLATELET REFRACTORINESS: PATIENT EVALUATION AND PRODUCT SELECTION

This course defines platelet refractoriness and describes the relevant antigens. Antigen typing and testing are reviewed. Finally, this educational session concludes with identification of the treatment options including their relative advantages and limitations.

TARGET AUDIENCE/PREREQUISITES: This activity has been designed for general, specialty, and subspecialty physicians who prescribe blood products, care for blood donors or have related interests. There are no participant prerequisites for this activity.

SUCCESS® CREDITS: 1.0 AMA PRA Category 1 credit(s)TM through the SUCCESS® program

Enter Course

LEARNING OBJECTIVES
At the conclusion of this activity, participants should be able to:

  1. Define platelet refractoriness.
  2. Compare immune to non-immune platelet refractoriness.
  3. Summarize the different types of tests used in the evaluation of platelet refractoriness. 

LEARNING TASKS
To receive CMEU credit for this activity, participants must:

  1. Acknowledge your review of the activity prerequisites, objectives, disclosures, methods of physician participation and statements.  
  2. Review the presentation "Platelet Refractoriness: Patient Evaluation and Product Selection" or review the slides and accompanying notes available as a printable Adobe Reader® file.
  3. Take the online Post-Test.
  4. Complete the online Activity Evaluation.
  5. Print the certificate awarding 1.0 AMA PRA Category 1 creditTM through the SUCCESSTM program.

FACULTY
Randal B. Covin, MD
Medical Director, Pacific Northwest Region
American Red Cross Blood Services
Portland, OR

Logan Happney
MHLA Laboratory Technologist II, Carolinas Region
American Red Cross Blood Services
Charlotte, NC

ACTIVITY PLANNER
Liz Marcus
Director, Hospital Sales and Marketing
Biomedical Headquarters American Red Cross
Washington DC

DISCLOSURES
The faculty has indicated that he has no relevant financial relationships with commercial interests to disclose.  No commercial support was received for this activity.

DISCLAIMER
The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of the American Red Cross Biomedical Services. Information herein is presented for educational purposes only.

ACCREDITATION STATEMENT
The American Red Cross Biomedical Services (ARCBS) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

DESIGNATION STATEMENT
The American Red Cross Biomedical Services designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM ; physicians should only claim credit commensurate with the extent of their participation in the activity.

PASSING REQUIREMENTS
If you correctly answer 75% or more of the post-test items you may claim credit.

DISCLOSURE STATEMENT
All faculty participating in ARCBS continuing medical education programs are expected to disclose to learners whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s); faculty are also expected to disclose off-label and/or investigational uses of products under discussion.

RELEASE DATE: 01/06/2020

EXPIRATION DATE: 01/05/2023

ESTIMATED TIME TO COMPLETE ACTIVITY: 1.0 hour 

Last modified: Tuesday, January 14, 2020, 01:28 PM